Annovis Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.

About ANVS

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. 

CEO
Maria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees
6
Employees6
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2008
Founded2008
Employees
6
Employees6

ANVS Key Statistics

Market cap
198.75M
Market cap198.75M
Price-Earnings ratio
-2.19
Price-Earnings ratio-2.19
Dividend yield
—
Dividend yield—
Average volume
261.04K
Average volume261.04K
High today
$18.20
High today$18.20
Low today
$13.60
Low today$13.60
Open price
$13.97
Open price$13.97
Volume
1.06M
Volume1.06M
52 Week high
$22.49
52 Week high$22.49
52 Week low
$5.42
52 Week low$5.42
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.